Assises 2018 : Targets for Mabs Innovative Approaches for their Discovery & Validation

Meeting report – mAbs journal

Dear colleague,

We are proud to announce the 6th Antibody Industrial Symposium 2018 (AIS2018) that will be held the 25th and 26th of June 2018 in Montpellier, France. This congress, jointly organized by the scientific society LabEx MAbImprove and the industrial organization MabDesign, is part of the series of Industrial Symposia organized by MAbImprove since 2013 (Antibodies Biosimilars, MAbDosing, MAbDelivery, Current & Next Generation Antibody Formats, Antibody Drug Conjugates).

The AIS2018 is the ideal conference for scientists, industrials, physicians and policy makers to exchange about therapeutic antibodies.

The Scientific committee has set-up and exciting program around this year theme: “Targets for MAbs: Innovative approaches for their discovery & validation”, with keynote lectures, pitch talks around new creative projects, and industrial talks from big pharmaceutical companies.

The meeting is driven by the fact that the target selection is fundamental for the successful development of therapeutic antibodies. In different sessions we will address the following questions: What are the characteristics of « good » antibody targets? Which techniques can be used for their discovery & selection? Which path should one select for validating targets and bringing them to the clinics? What mode of action/function is preferred for a given target?

The program contains several opportunities for networking, companies to showcase their new products and technologies as well as dedicated time for business partnering.

The Symposium will take place at the “Le Corum” conference center in the heart of Montpellier providing easy transport link and plenty of accommodation close to the venue.

Looking forward to welcoming you to the 6th Antibody Industrial Symposium 2018 in Montpellier!

Best regards,

The Organizing Committee – LabEx MabImprove and MabDesign

The Scientific Committee

LabEx MabImprove MabDesign